SVB Leerink Maintains Outperform on Replimune Group, Lowers Price Target to $49

SVB Leerink analyst Jonathan Chang maintains Replimune Group (NASDAQ:REPL) with a Outperform and lowers the price target from $55 to $49.

SVB Leerink analyst Jonathan Chang maintains Replimune Group (NASDAQ:REPL) with a Outperform and lowers the price target from $55 to $49.

Total
0
Shares
Related Posts